115 related articles for article (PubMed ID: 9877183)
21. Palmitoylation of inducible nitric-oxide synthase at Cys-3 is required for proper intracellular traffic and nitric oxide synthesis.
Navarro-Lérida I; Corvi MM; Barrientos AA; Gavilanes F; Berthiaume LG; Rodríguez-Crespo I
J Biol Chem; 2004 Dec; 279(53):55682-9. PubMed ID: 15485846
[TBL] [Abstract][Full Text] [Related]
22. Beta-[3H]funaltrexamine-labeled mu-opioid receptors: species variations in molecular mass and glycosylation by complex-type, N-linked oligosaccharides.
Liu-Chen LY; Chen C; Phillips CA
Mol Pharmacol; 1993 Oct; 44(4):749-56. PubMed ID: 8232225
[TBL] [Abstract][Full Text] [Related]
23. The effects of recombinant rat mu-opioid receptor activation in CHO cells on phospholipase C, [Ca2+]i and adenylyl cyclase.
Smart D; Hirst RA; Hirota K; Grandy DK; Lambert DG
Br J Pharmacol; 1997 Mar; 120(6):1165-71. PubMed ID: 9134231
[TBL] [Abstract][Full Text] [Related]
24. Evidence that palmitoylation of carboxyl terminus cysteine residues of the human luteinizing hormone receptor regulates postendocytic processing.
Munshi UM; Clouser CL; Peegel H; Menon KM
Mol Endocrinol; 2005 Mar; 19(3):749-58. PubMed ID: 15539429
[TBL] [Abstract][Full Text] [Related]
25. [Binding characteristics of new synthesized opioid receptor ligands to cloned mu opioid receptors stably expressed in CHO cell].
Hu P; Ye CY; Qiu ZB; Yang HF; Zhang DC
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2003 Feb; 25(1):79-82. PubMed ID: 12905615
[TBL] [Abstract][Full Text] [Related]
26. Palmitoylation of the human bradykinin B2 receptor influences ligand efficacy.
Pizard A; Blaukat A; Michineau S; Dikic I; Müller-Esterl W; Alhenc-Gelas F; Rajerison RM
Biochemistry; 2001 Dec; 40(51):15743-51. PubMed ID: 11747451
[TBL] [Abstract][Full Text] [Related]
27. Evidence for a mu-delta opioid receptor complex in CHO cells co-expressing mu and delta opioid peptide receptors.
Rutherford JM; Wang J; Xu H; Dersch CM; Partilla JS; Rice KC; Rothman RB
Peptides; 2008 Aug; 29(8):1424-31. PubMed ID: 18472184
[TBL] [Abstract][Full Text] [Related]
28. A single residue, Lys108, of the delta-opioid receptor prevents the mu-opioid-selective ligand [D-Ala2,N-MePhe4,Gly-ol5]enkephalin from binding to the delta-opioid receptor.
Minami M; Nakagawa T; Seki T; Onogi T; Aoki Y; Katao Y; Katsumata S; Satoh M
Mol Pharmacol; 1996 Nov; 50(5):1413-22. PubMed ID: 8913373
[TBL] [Abstract][Full Text] [Related]
29. Palmitoylation of the murine leukemia virus envelope glycoprotein transmembrane subunits.
Yang C; Compans RW
Virology; 1996 Jul; 221(1):87-97. PubMed ID: 8661417
[TBL] [Abstract][Full Text] [Related]
30. Identification of the amino acid residues involved in selective agonist binding in the first extracellular loop of the delta- and mu-opioid receptors.
Fukuda K; Terasako K; Kato S; Mori K
FEBS Lett; 1995 Oct; 373(2):177-81. PubMed ID: 7589460
[TBL] [Abstract][Full Text] [Related]
31. The conserved cysteine 7.38 residue is differentially accessible in the binding-site crevices of the mu, delta, and kappa opioid receptors.
Xu W; Chen C; Huang P; Li J; de Riel JK; Javitch JA; Liu-Chen LY
Biochemistry; 2000 Nov; 39(45):13904-15. PubMed ID: 11076532
[TBL] [Abstract][Full Text] [Related]
32. The role of palmitoylation of the guanine nucleotide binding protein G11 alpha in defining interaction with the plasma membrane.
McCallum JF; Wise A; Grassie MA; Magee AI; Guzzi F; Parenti M; Milligan G
Biochem J; 1995 Sep; 310 ( Pt 3)(Pt 3):1021-7. PubMed ID: 7575398
[TBL] [Abstract][Full Text] [Related]
33. Agonist-induced signaling and trafficking of the mu-opioid receptor: role of serine and threonine residues in the third cytoplasmic loop and C-terminal domain.
Capeyrou R; Riond J; Corbani M; Lepage JF; Bertin B; Emorine LJ
FEBS Lett; 1997 Sep; 415(2):200-5. PubMed ID: 9350996
[TBL] [Abstract][Full Text] [Related]
34. A novel N-terminal motif for palmitoylation of G-protein alpha subunits.
Parenti M; Viganó MA; Newman CM; Milligan G; Magee AI
Biochem J; 1993 Apr; 291 ( Pt 2)(Pt 2):349-53. PubMed ID: 8484716
[TBL] [Abstract][Full Text] [Related]
35. Effects of chronic opioid exposure on guinea pig mu opioid receptor in Chinese hamster ovary cells: comparison with human and rat receptor.
Wallisch M; Nelson CS; Mulvaney JM; Hernandez HS; Smith SA; Olsen GD
Biochem Pharmacol; 2007 Jun; 73(11):1818-28. PubMed ID: 17343833
[TBL] [Abstract][Full Text] [Related]
36. Opioid peptide receptor studies. 16. Chronic morphine alters G-protein function in cells expressing the cloned mu opioid receptor.
Xu H; Lu YF; Rothman RB
Synapse; 2003 Jan; 47(1):1-9. PubMed ID: 12422367
[TBL] [Abstract][Full Text] [Related]
37. Fatty acylation of the rat and human asialoglycoprotein receptors. A conserved cytoplasmic cysteine residue is acylated in all receptor subunits.
Zeng FY; Weigel PH
J Biol Chem; 1996 Dec; 271(50):32454-60. PubMed ID: 8943311
[TBL] [Abstract][Full Text] [Related]
38. Characterisation and visualisation of [3H]dermorphin binding to mu opioid receptors in the rat brain. Combined high selectivity and affinity in a natural peptide agonist for the morphine (mu) receptor.
Amiche M; Sagan S; Mor A; Pelaprat D; Rostene W; Delfour A; Nicolas P
Eur J Biochem; 1990 May; 189(3):625-35. PubMed ID: 2161761
[TBL] [Abstract][Full Text] [Related]
39. Molecular cloning and functional expression of a mu-opioid receptor from rat brain.
Chen Y; Mestek A; Liu J; Hurley JA; Yu L
Mol Pharmacol; 1993 Jul; 44(1):8-12. PubMed ID: 8393525
[TBL] [Abstract][Full Text] [Related]
40. Identification in the mu-opioid receptor of cysteine residues responsible for inactivation of ligand binding by thiol alkylating and reducing agents.
Gaibelet G; Capeyrou R; Dietrich G; Emorine LJ
FEBS Lett; 1997 May; 408(2):135-40. PubMed ID: 9187354
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
